Nuvalent, Inc. (NUVL)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$123.960.00%
Close 2026-07-16 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · NUVL
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -0.0% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 399 industry peers · Company calendar date is not available
NUVL — legal / regulatory event — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar…
Dated 2026-07-15
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. In connection with the consummation of the Merger, the Company (i) notified The Nasdaq Stock Market LLC (“Nasdaq”) of the consummation of the Merger and (ii) requested that Nasdaq (x) halt trading of the Shares effective as of the evening of July 14, 2026 after market close and suspend trading in the Shares prior to market open on the morning of July 15, 2026, and (y) file with the SEC a Notif…
Why it matters: Losing more money might show bigger financial problems. This could hurt investor trust.
Worry ifOperating losses exceed -$119.4M in Q2 2026.
Less concerning ifOperating losses improve and fall below -$119.4M in Q2 2026.
Why it matters: Completion will make Nuvalent a wholly owned subsidiary. This will affect future plans.
Supportive ifMerger with GSK completes successfully in Q3 2026.
Worry ifMerger fails to complete or faces significant delays.
Why it matters: Managing losses is crucial for financial health. Improvement would signal better cost control.
Supportive ifOperating losses decrease by at least 10% in the next quarterly report.
Worry ifOperating losses increase or stay the same in the next quarterly report.
Why it matters: Completing the merger will make Nuvalent a wholly owned subsidiary. This may bring new resources and stability.
Supportive ifMerger with GSK is complete. Nuvalent is now a wholly owned subsidiary.
Worry ifMerger fails to complete by the end of Q3 2026.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$103 on $10,000 · ±1.0% | How much price usually moves either way. |
| Bad day | $396 loss on $10,000 · 4.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,098 loss on $10,000 · 21.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Continued high cash burn and losses could signal financial instability. Investors will want to see improvement in these areas.
Worry ifOperating losses decrease from $119.4 million in Q1 2026.
Less concerning ifOperating losses increase beyond $119.4 million in Q3 2026.